|
Issue 18, February 2006
Contamination in the
Pharmaceutical Industry
A waste or
rejection rate of 10%, unacceptable in most other industries, is
considered good in the pharmaceutical industry. (according to
Centre for Drug Evaluation and Research or CDER). Reject
rates of 30% are not unknown for some production processes.
Contamination is the main problem type.
Contamination control
is a task that affects practically every area of pharmaceutical
production. Parenterals often entail volatile drugs and high-risk routes
of administration, so regardless of what filling method is used—from
aseptic processing to barrier isolation to blow-fill-seal—pharmaceutical
companies must be extremely alert for potential contamination.
As with most
industries, it is important to identify the type, identity, source and
extent of contamination in order to manage the risk associated with
these areas appropriately. Without all this information, the right
decisions cannot be made.
Identifying unknown
contaminants is crucial to improving the bottom line for the
industry.
This often requires the skill of a research scientist/project manager.
The internal training of production staff in the exploratory techniques
to solve these problems is usually both time consuming and cost
inefficient for what is generally considered a "one-off".
Contamination
identification and characterisation require specialist knowledge and an
understanding of the availability and limitations of current techniques.
These techniques include:
- Advanced NMR
programs (NOESY, APT COSY, HETCOR and PWGNMR)
- NIR, FTIR and
Raman Spectroscopy
- Particle
characterisation microscopy
- SEM-EDX
spectroscopy
- Mass spectrometry
(accurate mass, ESI, IE, MALDI and APCI)
- GC/LC-MS
The ability to cross
reference techniques, in order to assure that all the data withstands
scrutiny, requires the individual to be trained and fluent in all
techniques. In addition, contamination issues arising between sites and
suppliers and contractors can result in litigation. Independent testing
and unbiased opinion aids resolution.
Cetec offers a total
solution package from initial consultancy, testing and investigation
through to risk assessment and management. Our highly qualified
consultants and NATA accredited laboratory are familiar with advances in
modern analysis techniques, air and water quality, and risk management.
Cetec also has an extensive network of contacts to University
laboratories and CSIRO.
Next issue we will look
at a typical process investigation in the pharmaceutical industry.
|
Select another
article from this issue: |
|